Raydiant Oxymetry

SAN RAMON, CA, November 5, 2025 - Raydiant Oximetry, Inc., a clinical-stage medical device company pioneering innovations in fetal monitoring through advanced biophotonics and machine learning, today announced the initiation of an Investigational Device E

Raydiant Oximetry, Inc., a clinical-stage medical device company pioneering innovations in fetal monitoring through advanced biophotonics and machine learning,

Raydiant Oximetry, Inc., a clinical-stage medical device company pioneering fetal monitoring innovations through advanced biophotonics and machine learning,

SAN RAMON, Calif., October 16, 2025 - Raydiant Oximetry, Inc., a clinical-stage medical device company pioneering fetal monitoring innovations through advanced biophotonics and machine learning, today announced the successful completion of a 35-patient Ea

SAN RAMON, CA, UNITED STATES, September 16, 2025 - Raydiant Oximetry, Inc. a clinical-stage medical device company developing fetal monitoring innovations using advanced biophotonics and machine learning to improve outcomes during childbirth, today announ

Raydiant Oximetry, Inc., a clinical-stage medical device company developing fetal monitoring innovations using advanced biophotonics and machine learning to

GE HealthCare and Raydiant Oximetry, Inc. today announced a joint development initiative to enhance fetal monitoring capabilities that could strengthen the support of clinical decision-making during labor. This effort leverages the combined expertise and

This challenge, co-sponsored by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the Bill & Melinda Gates Foundation, aims to accelerate the development of advanced fetal monitoring technologies to improve fe